Prostatype Genomics AB's market cap is currently €21.31M. The company's EPS TTM is kr-0.646; its P/E ratio is ―; Prostatype Genomics AB is scheduled to report earnings on July 23, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
Prostatype Genomics AB Earnings and Revenue History
